Remove 2024 Remove Article Remove Documentation Remove Pharmaceutical Companies
article thumbnail

ICH Q13 and What Is Next for Continuous Manufacturing

ISPE

1 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. This article highlights the overall benefits and scope of Q13, as well as what we see as the next set of opportunities to further expand the adoption of CM across the globe.